非瓣膜性房颤患者应用达比加群相关出血事件的危险因素分析
The risk factor of hemorrhage among patients with nonvalvular atrial fibrillation initiated dabigatran therapy
{{custom_ref.label}} |
{{custom_citation.content}}
{{custom_citation.annotation}}
|
/
〈 | 〉 |